UriLadabaumMD
Gastroenterology • Stanford, CAAssociate Professor, Medicine - Gastroenterology & Hepatology, Stanford University Medical Center
Dr. Ladabaum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
University of MichiganFellowship, Gastroenterology, 1995 - 1998
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1991 - 1995
University of California San Francisco School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1992 - 2026
MI State Medical License 1998 - 2002
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Citalopram in Irritable Bowel Syndrome Start of enrollment: 2001 Apr 01
- Does Knowing One's Estimated Colorectal Cancer Risk Influence Screening Behavior? Start of enrollment: 2015 Oct 06
- Outreach and Choice in Colorectal Cancer Screening Start of enrollment: 2021 Aug 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation.Junyi Sun, Lu Ren, Gabriela Canel Rivero, Lingyun Xu, Uri Ladabaum
Stem Cell Research. 2024-12-01 - Projected Impact and Cost-Effectiveness of Novel Molecular Blood-Based or Stool-Based Screening Tests for Colorectal Cancer.Uri Ladabaum, Ajitha Mannalithara, Robert E Schoen, Jason A Dominitz, David Lieberman
Annals of Internal Medicine. 2024-12-01 - Reply.Uri Ladabaum, Ajitha Mannalithara, Robert E Schoen, Jason A Dominitz, David Lieberman
Gastroenterology. 2024-12-01
Journal Articles
- Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. MedicareJoel V Brill, Uri Ladabaum, Nature
Press Mentions
Cell-Free Blood DNA Tests Less Effective Than Other CRC ScreeningOctober 31st, 2024- New Colorectal Cancer Blood Tests Not as Effective as ColonoscopyOctober 29th, 2024
- Stanford Study Reveals Blood Tests for Colon Cancer Fall Short of Colonoscopy EffectivenessOctober 28th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
